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Purpose. Dental hygienists, dentists, and other workforce providers who depend upon their hands for employment are acutely aware
of the need to protect their hands to ensure a successful career. Recent research has suggested that smoking may be protective of hand
osteoarthritis. The purpose of this study is to determine the association between smoking and Heberden’s nodes. Methods. Data from
the Osteoarthritis Initiative were used in a cross-sectional, secondary data analysis of self-reported current smoking/never smoking
and the presence/absence of Heberden’s nodes, the hard enlargements of the joints nearest the fingertips (distal interphalangeal
joints). Analyses included descriptive statistics, Chi-square associations with Heberden’s nodes, and logistic regressions. Results. In
adjusted analysis, smoking had an adjusted odds ratio for Heberden’s nodes of 0.832 [95% confidence interval: 0.60, 1.14] which
failed to reach significance (𝑃 = .2488). In the selected model, females were more likely than males to have Heberden’s nodes;
non-Hispanic Blacks were less likely than non-Hispanic Whites to have Heberden’s nodes; and older age groups were more likely
than the youngest age group to have Heberden’s nodes. Conclusion. Smoking did not provide protection against Heberden’s nodes
in this study of US participants in the Osteoarthritis Initiative.

1. Introduction
Osteoarthritis is the most common form of arthritis involving
entire joints (cartilage, joint lining, ligaments, and underlying
bone) [1] and mainly affecting the axial skeleton and large
appendicular joints [2]. Over 21% of US adults (an estimated
46.4 million) have osteoarthritis [3]. When considering lifetime risk of symptomatic osteoarthritis, researchers reported
nearly 50% of adults will develop osteoarthritis by age of
85 years [4]. Many of the epidemiological researchers for
osteoarthritis have considered various predictors and associated morbidities involved with osteoarthritis. It has been
associated with body mass index [5], low Vitamin D [6, 7],
and increased consumption of soft drinks in men [8] and
in women with limited milk consumption [9], not breastfeeding [10], and giving birth [10]. Inconclusive and contradictory associations have been reported concerning associations of osteoarthritis and sex in which some researchers

found positive associations [7, 11, 12] while others did not [13]
and with smoking in which some researchers found positive
associations [14], others found protective associations [15, 16],
and others did not find any association [13].
Hand osteoarthritis is highly prevalent, impacts function,
and leads to considerable pain, stiffness, and disability [17, 18].
There are 26.2% of women and 13.4% of men aged 71 years
and above who have hand osteoarthritis [19]. In an age-sex
standardized analysis, researchers reported an incidence of
hand osteoarthritis of 100/100,000 person-years (as compared
with 88/100,000 person-years for the hip) [20]. Nevertheless,
epidemiological studies of hand osteoarthritis are limited
[18, 19]. Hands often develop hard tissue enlargements. If the
enlargements involve the joints nearest the fingertips, which
are the distal interphalangeal joints, the enlargements are
termed Heberden’s nodes. If the enlargements involve the 2nd
joints from the fingertips, which are the proximal interphalangeal joints, the enlargements are termed Bouchard’s nodes.
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Hand osteoarthritis has been defined as the presence of (1) hand pain/aching/stiffness; (2) at least 2 bony
nodes on the 2nd/3rd distal/proximal interphalangeal/first
trapeziometacarpal (base of thumb) joints; (3) less than
3 swollen metacarpophalangeal joints; and (4) at least 2
Heberden’s nodes, or deformity of at least 2 of the 2nd/3rd distal/proximal interphalangeal/first trapeziometacarpal joints
[21]. The disease process for hand osteoarthritis is poorly
understood, and it is yet to be determined if metabolic
factors are involved [18]. Some researchers have indicated that
the hard tissue enlargements on the distal interphalangeal
joints, Heberden’s nodes, may be genetic markers for general
arthritis [22]. If this is the case, an environmental factor, such
as smoking, may have an epigenetic role [23].
Smoking is a potentially modifiable risk factor for many
conditions and diseases including lung cancer and other
cancers, coronary heart disease and other heart diseases,
cerebrovascular disease and other vascular diseases, diabetes
mellitus, respiratory diseases (including chronic obstructive
pulmonary disease), rheumatoid arthritis, sudden unexplained infant death, inflammation, adverse effects on the
immune system, and bone health [24]. Smoking causes more
than 480,000 deaths annually in the US [24]. In a report of
the U.S. Department of Health and Human Services (2014)
[24], the authors indicated that smoking harms nearly every
organ in the body. There is a biological plausibility that smoking is associated with hand osteoarthritis and one feature
in particular—Heberden’s nodes. Previous researchers have
reported conflicting results as to the association of smoking
and osteoarthritis in general and smoking with Heberden’s
nodes [2]. The purpose of this study is to determine the
association of smoking and Heberden’s nodes.

2. Materials and Methods
2.1. Data Source. The data used in the preparation of
this paper were obtained from the Osteoarthritis Initiative
(OAI) database, which is available for public access at
http://www.oai.ucsf.edu/. Specific datasets used were from
the version 0.2.2 (2009) physical exam/measurements file:
subject characteristics file; risk factors file; joint symptoms/function file; biomarkers file; and medical history file.
The version V21 (2015) enrollee file was also used.
The researchers for the OAI conducted a longitudinal
study at four clinical centers (Brown University School of
Medicine/Memorial Hospital of Rhode Island in Pawtucket;
The Ohio State University in Columbus; University of Pittsburgh in Pittsburgh; and University of Maryland/John Hopkins University in Baltimore) and one data collection center
(University of California, San Francisco School of Medicine)
in a design to develop public domain osteoarthritis research
through the development and maintenance of an osteoarthritis natural history database containing biochemical, genetic,
and imaging biomarkers for osteoarthritis [25]. Participant
exclusion criteria included refusal to sign informed consent documents, self-reported prevalent rheumatoid arthritis,
bilateral total knee replacement or expected bilateral knee
replacement within 3 years, severe joint space narrowing in
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both knees determined at baseline, pregnancy, the use of
more than a single cane to aid in walking for more than
50% of the time, conditions which might cause an inability
to participate in the entire length of the study, potential move
from the clinic area within 3 years, enrollment as a participant
in a double-blind randomized controlled study, inability to
have a 3.0 Tesla MRI, or inability to provide a blood sample
[25]. There were 4769 participants, aged 45–79 years, in the
source data from which our sample was drawn. Additional
documentation describing various aspects of the design and
methods of the OAI is available at the OAI online website
(http://www.oai.ucsf.edu/).
2.2. Participant Eligibility. Participants for this study were
included if they (1) were current or never smokers; (2)
provided a response to the question about any obvious
hard bumps on the joints nearest to the fingertips; and
(3) had complete data on the other variables of interest in
the study (age, sex, race/ethnicity, alcohol use, educational
level, comorbidities, height, weight, family history, physical
summary score, and knee osteoarthritis). Participants were
excluded if they were former smokers or if they did not
provide a response concerning any obvious hard bumps on
the joints nearest to the fingertips or had incomplete data on
the other variables of interest in the study. From the 4769
participants in the OAI, there were 2723 participants who
had data on all of the variables of interest and were therefore
eligible for this study.
2.3. Key Dependent Variable. The presence or absence (yes,
no) of Heberden’s nodes was the key dependent variable. It
was determined by the self-report of the participant of any
obvious hard bumps on the joints nearest to the fingertips.
This was a question asked during the initial eligibility interview.
2.4. Key Independent Variable. The key independent variable
is smoking (current, never). Never smoking was determined
by the self-report of the participant that he or she had never
smoked 100 cigarettes (5 packs) in his or her life. A followup question of current smoking status identified current
smokers. Former smokers were excluded from the study.
2.5. Other Variables. Also included in the analyses were sex
(male, female); age (45 to less than 56 years, 56 to less
than 66 years, and 66 years and above); race/ethnicity (nonHispanic White, non-Hispanic Black, and Hispanic/other);
education (high school graduate or less, more than high
school graduate); body mass index (less than 25, 25 to less
than 30, and 30 and above); Charlson index (0, 1, and
above); and mother/father/sister/brother having had knee
replacement (yes, no). The presence of knee osteoarthritis
was determined by the right-side baseline radiographs scored
on the composite quasi-Kellgren and Lawrence graded as (0)
normal, (1) possible, (2) mild, (3) moderate, and (4) severe
OA. Physical summary scores (categorized as quartiles)
from the Medical Outcomes Study Short Form-12 version 2
physical summary scale were also included.
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2.6. Statistical Analyses. The analyses for the study were
conducted using SAS 9.2 software (SAS Institute, Chicago,
IL). The data were analyzed for a description of the sample
characteristics, bivariate analyses of the variables by Heberden’s nodes, and logistic regression on Heberden’s nodes.
Unadjusted and adjusted logistic regressions were completed
using the eligible participants as the domain in the analyses.

3. Results and Discussion
The sample consisted of 2723 participants. There were 59.7%
(1625) females, 78.9% (2148) non-Hispanic Whites, 19.0%
(516) non-Hispanic Blacks, and 2.2% (59) Hispanic/other. In
terms of age groups, there were 38.5% (1047) participants
aged 45 to less than 56 years; 30.4% (827) aged 56 to less
than 66 years; and 31.2% aged 66 years and above. There were
26.0% with a body mass index below 25 (normal weight);
38.7% with a body mass index between 25 and less than
30 (overweight); and 35.3% with a body mass index of 30
or above (obese). Most participants (76.2%) had a Charlson
index of 0 and an education above high school (84.1%)
and did not have a mother/father/sister/brother who had a
knee replacement. There were 18.8% of participants who had
a normal right knee radiographic evaluation and 5.5% of
participants who had a severe right knee radiographic evaluation. There were 30.1% (819) of participants who reported
having Heberden’s nodes and 11.4% (310) of participants who
reported current smoking. The Medical Outcomes Study
Short Form-12 version 2 physical summary scale quartile cutpoints were 43.06, 51.24, and 56.14 for 25%, 50%, and 75%,
respectively. Details of the analyses are presented in Table 1.
Table 2 includes the results of the Chi-square analyses
between Heberden’s nodes and the variables. Smoking, the
key independent variable of interest, was significantly related
to Heberden’s nodes (𝑃 = .0006). Other significant relationships with Heberden’s nodes were with sex, race/ethnicity,
age, body mass index, right knee radiographic evaluation,
mother/father/sister/brother who had a knee replacement,
education, and the Medical Outcomes Study Short Form-12
version 2 physical summary scale quartiles. Charlson index
and alcohol usage failed to reach significance in association
with Heberden’s nodes.
Table 3 includes the results of the logistic regressions
of smoking on Heberden’s nodes. In unadjusted analysis,
current smokers were less likely to have Heberden’s nodes
than never smokers (less than 5 packs/lifetime). The odds
ratio for current smokers, as compared with never smokers,
was 0.61 (95% confidence interval: 0.46, 0.81; 𝑃 = .0007).
When the other significant variables were included in the
model, smoking was attenuated to an adjusted odds ratio
of 0.83 [95% confidence interval: 0.60, 1.14] which failed to
reach significance (𝑃 = .2488). In the selected model, females
were more likely than males to have Heberden’s nodes; nonHispanic Blacks were less likely than non-Hispanic Whites
to have Heberden’s nodes; older age groups were more likely
than the youngest age group to have Heberden’s nodes; people
in the lower quartiles on the Medical Outcomes Study Short
Form-12 version 2 physical summary scale were more likely
to have Heberden’s nodes than people in the highest quartile;
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Table 1: Sample description, Osteoarthritis Initiative data.

All
Heberden’s nodes
Yes
No
Smoking
Yes, current
Never (<5 packs/lifetime)
Sex
Female
Male
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic/other
Age in years
45 to <56
≥56 to <66
≥66
Body mass index
<25 (normal weight)
≥25 to <30 (overweight)
≥30 (obese)
Right knee radiographic evaluation
Normal
Possible osteoarthritis
Mild
Moderate
Severe
Family history of osteoarthritis
Yes
No
Charlson index
0
≥1
Education
High school or less
More than high school
Alcohol use (drinks/week)
0–3
4–7
8–14
15 and above
1
Medical Outcomes Study Short Form-12
Quartile 1
Quartile 2
Quartile 3
Quartile 4

Number
2723

Percent
100

819
1904

30.1
69.9

310
2413

11.4
88.6

1625
1098

59.7
40.3

2148
516
59

78.9
18.9
2.2

1047
827
849

38.5
30.4
31.2

709
1054
960

26.0
38.7
35.3

512
957
544
559
151

18.8
35.1
20.0
20.5
5.5

248
2475

9.1
90.9

2074
649

76.2
23.8

434
2289

15.9
84.1

2084
355
198
86

76.5
13.0
7.3
3.2

655
668
643
757

24.1
24.5
23.6
27.8

1
Medical Outcomes Study Short Form-12 version 2 physical summary scale
quartile cut-points: 25% = 43.06; 50% = 51.24; and 75% = 56.14.

and people with a BMI of 30 and above were less likely to have
Heberden’s nodes than people with a BMI of less than 25.
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Table 2: Chi-square analysis of Heberden’s nodes by the variables,
Osteoarthritis Initiative data.
Heberden’s nodes
Smoking
Yes, current
Never (<5 packs/lifetime)
Sex
Female
Male
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic/other
Age
45 to <56
≥56 to <66
≥66
Body mass index
<25 (normal weight)
≥25 to <30 (overweight)
≥30 (obese)
Right knee radiographic
evaluation
Normal
Possible osteoarthritis
Mild
Moderate
Severe
Family history of
osteoarthritis
Yes
No
Charlson index
0
≥1
Education
High school or less
More than high school
Alcohol use (drinks/week)
0–3
4–7
8–14
15 and above
1
MOS SF-12 quartiles
Quartile 1
Quartile 2
Quartile 3
Quartile 4
1

Yes

Row
%

67
752

21.6
31.2

647
172

39.8
15.7

706
90
23

32.9
17.4
39.0

187
269
363

17.9
32.5
42.8

247
330
242

34.8
31.3
25.2

Row
𝑃 value
%
.0006
243 78.4
1661 68.8
<.0001
978 60.2
926 84.3
<.0001
1442 67.1
426 82.6
36
61.0
<.0001
860 82.1
558 67.5
486 57.2
<.0001
462 65.2
724 68.7
718 74.8

24.2
30.1
32.7
32.4
31.8

388
669
366
378
103

75.8
69.9
67.3
67.6
68.2
.0172

91
728

36.7
29.4

157
1747

63.5
70.6

621
198

29.9
30.5

1453
451

70.1
69.5

158
661

36.4
28.9

276
1628

63.6
71.1

646
104
45
24

31.0
29.3
22.7
27.9

1438
251
153
62

69.0
70.7
77.3
72.1

.7836

.0017

.1025

.0037
218
217
193
191

33.3
32.5
30.0
25.2

Odds ratio
[confidence
interval]

No.

.0190
124
288
178
181
48

Table 3: Odds ratios and 95% confidence intervals from logistic
regression on Heberden’s nodes, Osteoarthritis Initiative data.

437
451
450
566

66.7
67.5
70.0
74.8

Medical Outcomes Study Short Form-12 version 2 physical summary scale.

Unadjusted
Smoking
Yes, current
Never (<5 packs/lifetime)
Adjusted model
Smoking
Yes, current
Never (<5 packs/lifetime)
Sex
Female
Male
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic/other
Age
45 to <56
≥56 to <66
≥66
Body mass index
<25 (normal weight)
≥25 to <30 (overweight)
≥30 (obese)
Right knee radiographic evaluation
Normal
Possible osteoarthritis
Mild
Moderate
Severe
Family history of osteoarthritis
Yes
No
Education
High school or less
More than high school
MOS SF-12 quartiles1
Quartile 1
Quartile 2
Quartile 3
Quartile 4
1

The purpose of this study was to explore the association
of smoking and Heberden’s nodes. The results were that the
adjusted odds ratio for smoking on Heberden’s nodes failed
to reach significance (𝑃 = .2337). Interaction analysis with
family history did not change the results. However, female
smokers and female nonsmokers were more likely to have

0.61 [0.46, 0.81]
Referent

𝑃 value

.0007

.2488
0.83 [0.60, 1.14]
Referent
<.0001
3.65 [2.98, 4.48]
Referent
Referent
0.38 [0.29, 0.49]
1.12 [0.61, 2.08]

<.0001
.7094

Referent
1.97 [1.57, 2.48]
2.81 [2.22, 3.55]

<.0001
<.0001

Referent
1.02 [0.81, 1.27]
0.72 [0.57, 0.93]

.8988
.0105

Referent
1.16 [0.89, 1.52]
1.22 [0.90, 1.65]
1.16 [0.86, 1.58]
1.17 [0.74, 1.84]

.2722
.1984
.3359
.4998

1.24 [0.92, 1.69]
Referent

.1625

1.16 [0.91, 1.50]
Referent

.2372

1.53 [1.18, 1.98]
1.40 [1.09, 1.80]
1.28 [0.99, 1.64]
Referent

.0015
.0096
.0577

Medical Outcomes Study Short Form-12 version 2 physical summary scale.

Heberden’s nodes than male nonsmokers (AOR = 2.95 and
3.69, resp.; 𝑃 < .0001); and smokers aged 45–56 years,
smokers aged 56 years and above, and nonsmokers aged
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56 years and above were more likely to have Heberden’s nodes
than young nonsmokers (AOR = 1.24, 1.94, 3.00, resp.).
The literature has few studies involving the relationship
between hand osteoarthritis and smoking, [26]. There are
even fewer studies between Heberden’s nodes and smoking
with which we could compare our results. This study’s results
are similar to results of Haara et al. [26] who studied Kellgren
and Lawrence Grade 2 + osteoarthritis in any finger and
smokers who smoked 20 or more cigarettes per day. The
results in that study included an adjusted odds ratio of 0.72
[95% confidence interval: 0.48, 1.09] [26]. In a study of 443
Chuvashian (Russian) men, no association of smoking and
hand osteoarthritis was determined (Chi-square 𝑃 = .49)
[27].
This study’s results are also similar to the risk ratio for
current smoking on hand osteoarthritis in which the adjusted
odds ratio was 0.99 [95% confidence interval: 0.75, 1.31] [28].
The definition for smoking exposure (i.e., current smoking
and never smoking) used by Wilder et al. [28] was the same
as the definition used for this study. However, protective
results of smoking with Heberden’s nodes in women [29]
and protective results of smoking and osteoarthritis in knees
and large joints are also reported in the literature [15, 16,
30]. It has been suggested that there is a differential effect
of nicotine on human chondrocyte glycosaminoglycan and
collagen synthesis [31].
3.1. Plausible Biological Mechanism. It has been reported
that the relationship of smoking with Heberden’s nodes
and osteoarthritis is variable [2] and that the etiology of
osteoarthritis may be different at different body sites [16].
Additionally, the effects of nicotine may also be different at
different body sites [16]. Although nicotine was shown to be
beneficial to chondrocyte metabolism, it was also shown to
destroy chondrocytes at the intervertebral disk, but not at the
knee [31–33].

4. Conclusion
Workforce losses due to hand osteoarthritis would place a
great burden on society. This is particularly true for healthcare access to care issues in which certain professions require
repetitive motions (such as with dental hygiene). The public
health impact is a concern, especially for high risk, special
needs populations. Hand osteoarthritis and its implications
may become a factor in recruitment to various professions
and workforce numbers. Determining and understanding
factors associated with hand osteoarthritis and factors not
implicated with hand osteoarthritis are important for individuals and for workforce preparation.
We failed to reject the null hypothesis of no difference
in the number of Heberden nodes among individuals who
smoke and individuals who do not smoke; we did not provide
any clear evidence of a protective effect of smoking. These
findings are similar to the findings of many studies of smoking and hand osteoarthritis but are not similar to previous
findings concerning Heberden’s nodes in which smoking was
protective. The implications of this study are that smoking has
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not shown any beneficial effects in protecting the hands. With
current knowledge of the harms of smoking, this study adds
to the mounting knowledge in the literature that there are few
benefits and many known harms of smoking.

Additional Points
The researchers of the OAI intended to provide a wide
longitudinal database for public use; it was not intended to be
nationally representative. As a result, the number of smokers
in the study is not representative of the nation (11.4% in the
sample as compared with 17.8% nationally) [34]. This was
a limitation of the available data. There are limited studies
available to determine if the smoking exposure in studying
osteoarthritis should be current smoking, as is needed for
studies of myocardial infarctions, or if it should be packyears/total duration, as is needed for studies of lung cancer
[28]; therefore this limitation also applies to this study.

Ethical Approval
This cross-sectional study, a secondary data analysis (nonhuman subject research) of the OAI data, was acknowledged
by the West Virginia University Institutional Review Board
(Protocol no. 1509861595) and did not include experimentation involving human subjects or animals. The West Virginia
University Institutional Review Board does not approve nor
disapprove research which involves nonhuman subjects, such
as this project; however the members of the Board review the
protocol, acknowledge the review, and keep the protocol on
file. The research was conducted in full accordance with the
World Medical Association Declaration of Helsinki.
As with any study which relies upon self-report, there is
the possibility of misclassification due to inaccurate report
of smoking, Heberden’s nodes, or the other self-reported
variables. Self-reported data remains a weakness of all crosssectional studies. However, overall, the large sample made it
possible to include many additional variables in the model
in the explanation of the relationship of smoking and Heberden’s nodes. Additionally, the data were quality data intended
for secondary data analysis.
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